News
Stay up-to-date on the latest medical news—from the most current FDA-approved drugs to the latest statistics on chronic conditions.
Most Popular in News
FDA approves generic Xarelto
There’s a new—hopefully, lower cost—option for people who take anticoagulants to manage heart disease
Mar. 7, 2025
FDA approves rapid-acting insulin biosimilar
Merilog works like NovoLog to help control blood sugar when injected five to ten minutes before meals
Feb. 21, 2025
Ozempic for kidney disease
This diabetes medication is now indicated to prevent the worsening of kidney disease, kidney failure, and death due to cardiovascular disease
Jan. 31, 2025
Most Recent
Widaplik for hypertension
It’s a new triple combination medication to treat high blood pressure
Jun. 16, 2025
Statin statistics 2025
How many people are taking statins, how much we spend on these cholesterol-lowering drugs, and more
Jun. 5, 2025
Insulin statistics 2025
How many people rely on insulin around the world, how insulin prices have changed, and more
Jun. 5, 2025
Fentanyl facts and statistics
Current fentanyl stats, overdose facts, and why it’s so dangerous when misused
May 6, 2025
Ozempic statistics 2025
How many people are using Ozempic in 2025?
Apr. 22, 2025
FDA approves generic Xarelto
There’s a new—hopefully, lower cost—option for people who take anticoagulants to manage heart disease
Mar. 7, 2025
FDA approves rapid-acting insulin biosimilar
Merilog works like NovoLog to help control blood sugar when injected five to ten minutes before meals
Feb. 21, 2025
Ozempic for kidney disease
This diabetes medication is now indicated to prevent the worsening of kidney disease, kidney failure, and death due to cardiovascular disease
Jan. 31, 2025
FDA approves first generic once-daily GLP-1
Liraglutide, the generic of Victoza, is now available to treat Type 2 diabetes, alongside diet and exercise
Jan. 2, 2025
Zepbound for sleep apnea
It’s the first medication that reduces symptom severity, reducing breathing interruptions at night
Jan. 2, 2025
FDA issues warning to GLP-1 compounders
The U.S. Food and Drug Administration is sounding the alarm about the risks of taking unapproved versions of Ozempic, Wegovy, Zepbound, and Mounjaro
Dec. 19, 2024